
    
      The investigators research question is to determine if 2% topical lidocaine gel, instilled
      into the cervical canal, will reduce maximum pain at time of insertion of a popular IUD
      (Mirena Intrauterine System) in young, nulliparous patients. This will be studied in a
      randomized, double-blind placebo-controlled trial.
    
  